PharmaSynth plays an important role in supplying precursors and standards for PET and SPECT imaging, following GMP guidelines. Our special expertise relies in molecule synthesis for brain studies and we take fast steps into becoming an important partner in oncology and other applications. What makes us competitive is the quality we deliver through our products, the personal assistance and reliability we offer to our clients and the tailored products that serve to our customer's research goals.
| Website | http://www.pharmasynth.ee |
| Employees | 9 (4 on RocketReach) |
| Founded | 2004 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Radiochemistry, Pharmaceutical Synthesis, Brain Imaging, Imaging Agents, Custom Synthesis, Neuroimaging, Pharmaceutical Intermediates, Contract Manufacturing, Preclinical Imaging, Drug Development, Pharmaceutical Development, Chemical Synthesis |
| Competitors | Roche, Novartis, Boehringer Ingelheim, Pfizer, Merck & Co., Inc., GSK, AbbVie, AstraZeneca, Sanofi, Bristol Myers Squibb +45 more (view full list) |
Looking for a particular PharmaSynth AS employee's phone or email?
PharmaSynth AS Questions
Jukka Hiltunen is the CEO of PharmaSynth AS.
4 people are employed at PharmaSynth AS.
Top PharmaSynth AS Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
